AAAAAA
Results:
1-11
|
Results: 11
Authors:
Shimizu, K
Nagura, E
Hirabayashi, N
Wakita, A
Takeyama, H
Sao, H
Nitta, M
Kawashima, K
Saito, H
Citation: K. Shimizu et al., Posttreatment nadir M-protein level is a stronger discriminator of survival following plateau attainment than is percent reduction in M-protein in patients with IgG myeloma, INT J HEMAT, 74(2), 2001, pp. 205-208
Authors:
Utsunomiya, A
Miyazaki, Y
Takatsuka, Y
Hanada, S
Uozumi, K
Yashiki, S
Tara, M
Kawano, F
Saburi, Y
Kikuchi, H
Hara, M
Sao, H
Morishima, Y
Kodera, Y
Sonoda, S
Tomonaga, M
Citation: A. Utsunomiya et al., Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation, BONE MAR TR, 27(1), 2001, pp. 15-20
Authors:
Ohnishi, K
Minami, S
Ueda, T
Nishimura, M
Tsubaki, K
Takemoto, Y
Takeshita, A
Sao, H
Kageyama, S
Ueda, R
Ohno, R
Citation: K. Ohnishi et al., Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia, INT J HEMAT, 72(2), 2000, pp. 229-236
Authors:
Sao, H
Kato, C
Kitaori, K
Adachi, T
Yano, K
Kobayashi, M
Kojima, H
Tanimoto, M
Hirabayashi, N
Minami, S
Yamada, H
Morishita, Y
Morishima, Y
Kodera, Y
Citation: H. Sao et al., Effective and safe interferon treatment for Japanese patients with chronicmyelogenous leukemia relapse after bone marrow transplantation, INT J HEMAT, 72(2), 2000, pp. 237-242
Authors:
Yano, K
Kanie, T
Okamoto, S
Kojima, H
Yoshida, T
Maruta, I
Dohi, H
Morishita, Y
Ozawa, K
Sao, H
Sakamaki, H
Hiraoka, S
Imoto, S
Morishima, Y
Kodera, Y
Citation: K. Yano et al., Quality of life in adult patients after stem cell transplantation, INT J HEMAT, 71(3), 2000, pp. 283-289
Authors:
Gomyo, H
Murayama, T
Kizaki, T
Mizuno, I
Kitaori, K
Sao, H
Tobinai, K
Koizumi, T
Imoto, S
Citation: H. Gomyo et al., Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation, BONE MAR TR, 26(5), 2000, pp. 577-579
Authors:
Shimokawa, T
Morishima, Y
Kitaori, K
Kato, C
Sao, H
Citation: T. Shimokawa et al., Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors, INT J HEMAT, 70(2), 1999, pp. 119-126
Authors:
Obama, K
Tara, M
Sao, H
Taji, H
Morishima, Y
Mougi, H
Maruyama, Y
Osame, M
Citation: K. Obama et al., Allogenic bone marrow transplantation as a treatment for adult T-cell leukemia, INT J HEMAT, 69(3), 1999, pp. 203-205
Authors:
Sao, H
Kitaori, K
Kasai, M
Shimokawa, T
Kato, C
Yamanishi, H
Ueda, R
Morishima, Y
Citation: H. Sao et al., A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: resultsof a phase I-II trial, INT J HEMAT, 69(1), 1999, pp. 27-35
Authors:
Shimizu, K
Kamiya, O
Hirabayashi, N
Ichikawa, A
Kawashima, K
Kobayashi, M
Mizuno, H
Nagura, E
Nitta, M
Saito, H
Sao, H
Shibata, T
Takeyama, H
Citation: K. Shimizu et al., Posttreatment M-protein nadir level is a significant prognostic factor associated with survival in multiple myeloma, JPN J CANC, 90(3), 1999, pp. 355-360
Authors:
Kodera, Y
Morishima, Y
Kato, S
Akiyama, Y
Sao, H
Matsuyama, T
Kawa, K
Sakamaki, H
Nakagawa, S
Hirabayashi, N
Dohi, H
Okamoto, S
Hiraoka, A
Gondo, H
Tsuchida, M
O, H
Harada, M
Asano, S
Juji, T
Sasazuki, T
Takaku, F
Citation: Y. Kodera et al., Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia, BONE MAR TR, 24(9), 1999, pp. 995-1003
Risultati:
1-11
|